H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Immunology D-index 60 Citations 11,411 150 World Ranking 1745 National Ranking 147

Overview

What is he best known for?

The fields of study he is best known for:

  • Immune system
  • Gene
  • Internal medicine

His primary areas of study are Immunology, Leishmania donovani, Antigen, Spleen and Visceral leishmaniasis. His work in Immunity, Leishmaniasis, Immune system, Cytokine and T cell are all subfields of Immunology research. Leishmania donovani is a subfield of Leishmania that Paul M. Kaye tackles.

His Leishmania research incorporates elements of Macrophage, Monoclonal antibody, Intracellular parasite and Virology. His Antigen research is multidisciplinary, relying on both Tumor necrosis factor alpha, Leishmania infantum, Antibody and T cell immunology. The various areas that he examines in his Spleen study include Immunotherapy and Pathology.

His most cited work include:

  • Leishmaniasis: complexity at the host–pathogen interface (553 citations)
  • The role of dendritic cells in the induction and regulation of immunity to microbial infection. (287 citations)
  • Leishmaniasis: new approaches to disease control (249 citations)

What are the main themes of his work throughout his whole career to date?

Paul M. Kaye mainly focuses on Immunology, Leishmania donovani, Visceral leishmaniasis, Immune system and T cell. Paul M. Kaye frequently studies issues relating to Leishmania and Immunology. His work in Leishmania donovani covers topics such as Bone marrow which are related to areas like Haematopoiesis and Stromal cell.

As part of one scientific family, he deals mainly with the area of Visceral leishmaniasis, narrowing it down to issues related to the Interleukin 10, and often Interleukin 4. His T cell research includes elements of Molecular biology, Dendritic cell, CD8 and Cell biology. His research integrates issues of Leishmania major, Disease and Virology in his study of Leishmaniasis.

He most often published in these fields:

  • Immunology (62.07%)
  • Leishmania donovani (30.05%)
  • Visceral leishmaniasis (25.12%)

What were the highlights of his more recent work (between 2016-2021)?

  • Visceral leishmaniasis (25.12%)
  • Immunology (62.07%)
  • Immune system (22.17%)

In recent papers he was focusing on the following fields of study:

Paul M. Kaye mostly deals with Visceral leishmaniasis, Immunology, Immune system, Leishmaniasis and Leishmania donovani. His Visceral leishmaniasis study integrates concerns from other disciplines, such as Internal medicine, Clinical trial, BALB/c, Host and Vaccination. His specific area of interest is Immunology, where Paul M. Kaye studies Inflammation.

When carried out as part of a general Immune system research project, his work on Immunity is frequently linked to work in Context, therefore connecting diverse disciplines of study. Paul M. Kaye has researched Leishmaniasis in several fields, including Transmission, Virology, Environmental health and Disease. His Leishmania donovani research integrates issues from Zoology, Vector, Anemia and Bone marrow.

Between 2016 and 2021, his most popular works were:

  • A third generation vaccine for human visceral leishmaniasis and post kala azar dermal leishmaniasis: First-in-human trial of ChAd63-KH (57 citations)
  • Skin parasite landscape determines host infectiousness in visceral leishmaniasis (31 citations)
  • In vivo imaging of systemic transport and elimination of xenobiotics and endogenous molecules in mice (30 citations)

In his most recent research, the most cited papers focused on:

  • Immune system
  • Gene
  • Internal medicine

His primary scientific interests are in Immunology, Visceral leishmaniasis, Leishmania donovani, Immune system and Leishmaniasis. Particularly relevant to T cell is his body of work in Immunology. Paul M. Kaye interconnects Macrophage, Disease and Leishmania in the investigation of issues within Visceral leishmaniasis.

His Leishmania donovani research is multidisciplinary, incorporating elements of Haematopoiesis and Bone marrow. His Immune system study incorporates themes from Spleen, Immunopathology and Vaccination. His Leishmaniasis research focuses on subjects like Virology, which are linked to Gene, Microbiology, Antigen and Pathogen.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Leishmaniasis: complexity at the host–pathogen interface

Paul Kaye;Phillip Scott.
Nature Reviews Microbiology (2011)

858 Citations

The role of dendritic cells in the induction and regulation of immunity to microbial infection.

Caetano Reis e Sousa;Alan Sher;Paul Kaye.
Current Opinion in Immunology (1999)

440 Citations

Leishmaniasis: new approaches to disease control

Clive R Davies;Paul Kaye;Simon L Croft;Shyam Sundar.
BMJ (2003)

425 Citations

DENDRITIC CELLS, BUT NOT MACROPHAGES, PRODUCE IL-12 IMMEDIATELY FOLLOWING LEISHMANIA DONOVANI INFECTION

Patricia M. A. Gorak;Christian R. Engwerda;Paul M. Kaye.
European Journal of Immunology (1998)

330 Citations

Locally Up-regulated Lymphotoxin α, Not Systemic Tumor Necrosis Factor α, Is the Principle Mediator of Murine Cerebral Malaria

Christian R. Engwerda;Tracey L. Mynott;Sanjeet Sawhney;J. Brian De Souza.
Journal of Experimental Medicine (2002)

298 Citations

Differential production of Th1- and Th2-derived cytokines does not determine the genetically controlled or vaccine-induced rate of cure in murine visceral leishmaniasis.

P M Kaye;A J Curry;J M Blackwell.
Journal of Immunology (1991)

266 Citations

The immunopathology of experimental visceral leishmaniasis

Paul M. Kaye;Mattias Svensson;Manabu Ato;Asher Maroof.
Immunological Reviews (2004)

248 Citations

Stromal Cells Direct Local Differentiation of Regulatory Dendritic Cells

Mattias Svensson;Asher Maroof;Manabu Ato;Paul M. Kaye.
Immunity (2004)

247 Citations

B Cell-Deficient Mice Are Highly Resistant to Leishmania donovani Infection, but Develop Neutrophil-Mediated Tissue Pathology

Sara C. Smelt;Sara E. J. Cotterell;Christian R. Engwerda;Paul M. Kaye.
Journal of Immunology (2000)

236 Citations

Natural antibodies and complement are endogenous adjuvants for vaccine-induced CD8+ T-cell responses.

Simona Stäger;James Alexander;Alun C Kirby;Marina Botto.
Nature Medicine (2003)

235 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Paul M. Kaye

Shyam Sundar

Shyam Sundar

Banaras Hindu University

Publications: 61

Christian R. Engwerda

Christian R. Engwerda

QIMR Berghofer Medical Research Institute

Publications: 51

Abhay R. Satoskar

Abhay R. Satoskar

The Ohio State University

Publications: 50

Manoel Barral-Netto

Manoel Barral-Netto

Oswaldo Cruz Foundation

Publications: 42

Alexandre Barbosa Reis

Alexandre Barbosa Reis

Universidade Federal de Ouro Preto

Publications: 42

Jenefer M. Blackwell

Jenefer M. Blackwell

University of Western Australia

Publications: 41

Mary E. Wilson

Mary E. Wilson

University of Iowa

Publications: 37

David L. Sacks

David L. Sacks

National Institutes of Health

Publications: 37

Aldina Barral

Aldina Barral

Oswaldo Cruz Foundation

Publications: 36

Cláudia Brodskyn

Cláudia Brodskyn

Oswaldo Cruz Foundation

Publications: 33

James Alexander

James Alexander

University of Strathclyde

Publications: 28

Phillip Scott

Phillip Scott

University of Pennsylvania

Publications: 28

Manuel Soto

Manuel Soto

Autonomous University of Madrid

Publications: 27

Arne Skerra

Arne Skerra

Technical University of Munich

Publications: 27

Hira L. Nakhasi

Hira L. Nakhasi

Center for Biologics Evaluation and Research

Publications: 27

Steven G. Reed

Steven G. Reed

Infectious Disease Research Institute

Publications: 25

Something went wrong. Please try again later.